Walgreens Boots Alliance (NASDAQ:WBA) Updates FY 2025 Earnings Guidance

Walgreens Boots Alliance (NASDAQ:WBA) issued an update on its FY 2025 earnings guidance on Friday morning. The company provided earnings per share guidance of 1.400-1.800 for the period, compared to the consensus earnings per share estimate of 1.520. The company issued revenue guidance of -. Walgreens Boots Alliance also updated its FY25 guidance to $1.40-$1.80 EPS.

Walgreens Boots Alliance Trading Up 27.5 %

Shares of Walgreens Boots Alliance stock opened at $11.76 on Friday. The company’s fifty day simple moving average is $9.26 and its 200-day simple moving average is $9.89. The stock has a market capitalization of $10.15 billion, a PE ratio of -1.17, a P/E/G ratio of 1.36 and a beta of 0.64. Walgreens Boots Alliance has a 1-year low of $8.08 and a 1-year high of $24.93. The company has a debt-to-equity ratio of 0.67, a current ratio of 0.68 and a quick ratio of 0.37.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings results on Friday, January 10th. The pharmacy operator reported $0.51 earnings per share for the quarter, topping the consensus estimate of $0.38 by $0.13. The business had revenue of $39.50 billion for the quarter, compared to analysts’ expectations of $37.40 billion. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The company’s revenue was up 7.6% compared to the same quarter last year. During the same quarter last year, the company posted $0.66 EPS. As a group, equities analysts anticipate that Walgreens Boots Alliance will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The company also recently disclosed a quarterly dividend, which was paid on Thursday, December 12th. Stockholders of record on Monday, November 18th were given a dividend of $0.25 per share. The ex-dividend date of this dividend was Monday, November 18th. This represents a $1.00 annualized dividend and a dividend yield of 8.50%. Walgreens Boots Alliance’s payout ratio is -9.99%.

Wall Street Analyst Weigh In

Several brokerages have recently commented on WBA. Barclays raised their price objective on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. TD Cowen decreased their price objective on shares of Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research report on Tuesday, October 22nd. Morgan Stanley decreased their price objective on shares of Walgreens Boots Alliance from $9.00 to $7.00 and set an “underweight” rating on the stock in a research report on Friday, October 11th. Evercore ISI lifted their price target on shares of Walgreens Boots Alliance from $7.50 to $10.00 and gave the company an “in-line” rating in a report on Wednesday, October 16th. Finally, Jefferies Financial Group reduced their price target on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Four investment analysts have rated the stock with a sell rating, nine have assigned a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and a consensus price target of $12.58.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.